Dr. Els Leys
ActiveDr. Els Leys has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €217k and a net result of €47k. Equity is growing by ~7.9% per year across the filed fiscal years. Its solvency ranks better than 84% of 16491 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
98
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability93▼-4
Solvency100▲+15
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €21k at 30 days acceptable
Liquidity ample (current ratio 9.75 against 2.48 in 2024; short-term debt: 9.5% and cash: 82.3% of total assets), and 9.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
90.5%
Return on assets
19.5%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-06-2026, 60 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
60 d early
2024
132 d early
2023
50 d early
2022
62 d early
2021
11 d early
2020
54 d early
2019
63 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
20-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€217k▲ 27.5%
2024 · €170k
2018: €129k
2019: €134k
2020: €124k
2021: €109k
2022: €132k
2023: €186k
2024: €170k
2018 → 2025
Total assets
€240k▼ 15.0%
2024 · €282k
2018: €166k
2019: €141k
2020: €150k
2021: €150k
2022: €157k
2023: €232k
2024: €282k
2018 → 2025
Net result
€47k▼ 25.9%
2024 · €63k
2018: €19k
2019: €5k
2020: €30k
2021: €6k
2022: €23k
2023: €54k
2024: €63k
2018 → 2025
Working capital
€200k▲ 20.5%
2024 · €166k
2018: €123k
2019: €120k
2020: €113k
2021: €101k
2022: €127k
2023: €184k
2024: €166k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€109k-€132k▲ 20.8%€186k▲ 41.2%€170k▼ 8.4%€217k▲ 27.5%
Operating result€13k-€37k▲ 184%€79k▲ 113%€90k▲ 14.4%€69k▼ 24.1%
Net result€6k-€23k▲ 251%€54k▲ 139%€63k▲ 16.6%€47k▼ 25.9%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 24% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €240k
Fixed assets
€17k▲ 290%
Current assets
€223k▼ 19.8%
Equity and liabilities €240k
Equity
€217k▲ 27.5%
Debt
€23k▼ 79.6%
The debt ratio falls from 39.7% to 9.5%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€72k▼
2024 · €91k
Cash flow
€51k▼
2024 · €64k
Solvency
90.5%▲
2024 · 60.3%
Current ratio
9.75▲
2024 · 2.48
Quick ratio
9.75▲
2024 · 2.48
Debt / equity
0.11▼
2024 · 0.66
ROE
21.6%▼
2024 · 37.1%
ROA
19.5%▼
2024 · 22.4%
Interest coverage
21.50▼
2024 · 37.74
Debt
€23k▼
2024 · €112k
Debt ≤ 1 year
€23k▼
2024 · €112k
Income taxes
€19k▼
2024 · €26k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€282k€240k▼
Fixed assets21/28€4k€17k▲
Tangible fixed assets22/27€4k€17k▲
Plant, machinery and equipment23€3k€4k▲
Furniture and vehicles24€1k€14k▲
Current assets29/58€278k€223k▼
Amounts receivable within one year40/41€0-
Other amounts receivable41€0-
Cash at bank and in hand54/58€249k€198k▼
Deferred charges and accrued income490/1€28k€25k▼
Equity and liabilities
Total equity and liabilities10/49€282k€240k▼
Equity10/15€170k€217k▲
Contributions10/11€5k€5k=
Reserves13€165k€212k▲
Distributable reserves133€165k€212k▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€112k€23k▼
Amounts payable within one year42/48€112k€23k▼
Trade debts44€5k€8k▲
Suppliers440/4€5k€8k▲
Taxes, remuneration and social security45€27k€12k▼
Taxes450/3€23k€7k▼
Remuneration and social security454/9€4k€4k▲
Other amounts payable47/48€79k€3k▼
Income statement
Code20242025
Non-recurring operating income76A€0-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€562€4k▲
Other operating charges640/8€3k€465▼
Gross operating margin9900€94k€73k▼
Operating profit (loss)9901€90k€69k▼
Financial income75/76B€1k€1k▼
Recurring financial income75€1k€1k▼
Financial charges65/66B€2k€3k▲
Recurring financial charges65€2k€3k▲
Profit (loss) for the period before taxes9903€89k€66k▼
Income taxes67/77€26k€19k▼
Profit (loss) for the period9904€63k€47k▼
Profit (loss) for the period to be appropriated9905€63k€47k▼
Appropriation of the result
Profit (loss) to be appropriated9906€63k€47k▼
Transfer from equity791/2€5k€0▼
Transfer to equity691/2€63k€47k▼
To other reserves6921€63k€47k▼
Profit to be distributed694/7€5k€0▼
Return on contributions (dividend)694€5k€0▼
The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
01-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Liquidity quadruplescurrent ratio 9.75
Current ratio from 2.48 to 9.75; short-term debt falls from €112k to €23k.
31-12
Financial
Equity above €200kEq €217k ▲27.5%
8 profitable years in a row build equity to €217k.
21-03
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2018net €63k ▲16.6%
Operating result €90k, net result €63k, both a record.
11-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Equity above €150kEq €186k ▲41.2%
6 profitable years in a row build equity to €186k.
30-05
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
20-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
07-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
29-05
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial
Weakest financial yearnet €5k ▼74.9%
Net result drops to €5k, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity quadruplescurrent ratio 17.58
Current ratio from 4.33 to 17.58; short-term debt falls from €37k to €7k.
17-06
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
28-05
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
07-06
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Bierbeek · 1 establishment unit since 2011
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Waversesteenweg(OPV) 23360 BierbeekGround area
1,582 m²
Building footprint
180 m²
Volume, LiDAR
807 m³
Parcel 24713D0089/00V000, Flanders · tallest building 7.9 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Dr. Els Leys
since 20112.196.449.192
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24713D0089/00V000 | Flanders | 1,582 m² | 1 · 180 m² | 7.8 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Société Médicale Docteur BALEINE
BE 0765.470.253
Estaimpuis · Eq €217k
DR. KAREL VAN IMSCHOOT, HUISARTS
BE 0821.285.241
Wetteren · Eq €217k
DR. JORN SIMONS
BE 1001.556.573
Turnhout · Eq €217k
DR. GULDENTOPS LAURA - HUISARTS
BE 0790.629.479
Lier · Eq €217k
DR VERMEERSCH Nele
BE 0682.886.532
Sint-Pieters-Leeuw · Eq €217k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,342 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded11-02-2011
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 15 filingsAddress and cadastre registers
Data from official sources, last processed on 18-09-2026. Scores and ratios are computed by Checked and are not a credit decision.